Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C25H23ClN2O4S
CAS Number:
Molecular Weight:
482.98
NACRES:
NA.21
SMILES string
C=CC(NC1=CC=CC=C1C2=CC=C(NC(CC3=CC=C(S(=O)(CC)=O)C=C3)=O)C=C2Cl)=O
assay
≥95% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Quality Level
Biochem/physiol Actions
Cell penetrant, highly potent, selective, and non-toxic RORγ covalent inhibitor.
W6134 is a highly potent, selective RORγ (retinoic acid receptor-related orphan receptor γ) armed with a cell-permeable acrylamide warhead, which specifically targets RORγ (IC50 = 210 nM in HEK293Tcells co-transfected with Gal4-RORγ-LBD) by covalently modifying RORγ-Cys320 thiol while showing minimal activity against other nuclear receptors such as RORα, RXRγ, and ERRγ (IC50 > 20 μM). W6134 is effective in inducing apoptosis in C4-2B and 22Rv1 cell lines and reduces RORγ-mediated transcription, leading to decreased androgen receptor (AR) expression in a dose- and time-dependent manner. When tested in vivo (T1/2 = 21.3 min in mouse liver microsomes), W6134 significantly suppresses tumor growth in castration-resistant prostate cancers (CRPC) xenograft mouse models (5 or 10 mg/kg, i.p.) demonstrating its efficacy and safety.
W6134 is a highly potent, selective RORγ (retinoic acid receptor-related orphan receptor γ) armed with a cell-permeable acrylamide warhead, which specifically targets RORγ (IC50 = 210 nM in HEK293Tcells co-transfected with Gal4-RORγ-LBD) by covalently modifying RORγ-Cys320 thiol while showing minimal activity against other nuclear receptors such as RORα, RXRγ, and ERRγ (IC50 > 20 μM). W6134 is effective in inducing apoptosis in C4-2B and 22Rv1 cell lines and reduces RORγ-mediated transcription, leading to decreased androgen receptor (AR) expression in a dose- and time-dependent manner. When tested in vivo (T1/2 = 21.3 min in mouse liver microsomes), W6134 significantly suppresses tumor growth in castration-resistant prostate cancers (CRPC) xenograft mouse models (5 or 10 mg/kg, i.p.) demonstrating its efficacy and safety.
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service